Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06968390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Accelerated TMS for Perinatal Depression

Study acronym: PAiNT
StatusRecruiting
PhaseNot applicable
Started2025-08-05
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 7 months later Nov 30, 2026 → Jul 2027
See other at-risk trials from Brigham and Women's Hospital

Amendment history

2026-09-19
Primary completion pushed: 2026-11-30 → 2027-07
Completion pushed: 2027-01-01 → 2028-07
2025-09-03
Study Status, Outcome Measures v2
Secondary endpointsdetails revised at 1 of 2 entries
Primary endpoints2 to 4 entries
Acceptability as measured by percentage of individuals who complete an entire treatment course Feasibility as measured by the number of individuals treated throughout the 50study Safety treatmentsas completedmeasured by reports of adverse events Tolerability as measured by incidenceratings of sidethe effectsClient onSatisfaction anQuestionnaire accelerated TMS sensations and adverse events questionnaire(CSQ-8)
2025-08-11
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-07-01→confirmed 2025-08-05
Study sitesdetails revised at 1 of 1 site
2025-05-05
Original filing
We are studying a treatment for depression called accelerated Transcranial Magnetic Stimulation (TMS) among pregnant and postpartum individuals. TMS is a focal, non-invasive form of brain stimulation that is cleared by the Food and Drug Administration for depression. Typically, traditional TMS involves daily treatments for 6-8 weeks. In this study, we will offer an accelerated form of TMS that involves multiple daily treatments for 5 days.
Trial Details
NCT Number NCT06968390
Lead Sponsor Brigham and Women's Hospital
Conditions Perinatal Depression, Post Partum Depression, Major Depressive Disorder
Enrollment 24 participants
Start Date 2025-08-05
Primary Completion 2027-07 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-09-18